Upstream Bio Inc
NASDAQ:UPB

Watchlist Manager
Upstream Bio Inc Logo
Upstream Bio Inc
NASDAQ:UPB
Watchlist
Price: 29.21 USD -4.01% Market Closed
Market Cap: 1.6B USD

Wall Street
Price Targets

UPB Price Targets Summary
Upstream Bio Inc

Wall Street analysts forecast UPB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UPB is 48.96 USD with a low forecast of 35.35 USD and a high forecast of 78.75 USD.

Lowest
Price Target
35.35 USD
21% Upside
Average
Price Target
48.96 USD
68% Upside
Highest
Price Target
78.75 USD
170% Upside
Upstream Bio Inc Competitors:
Price Targets
397030
AprilBio Co Ltd
0% Downside
RYTM
Rhythm Pharmaceuticals Inc
24% Upside
SYNACT
SynAct Pharma AB
11% Upside
002007
Hualan Biological Engineering Inc
26% Upside
DTIL
Precision BioSciences Inc
667% Upside
300685
Amoy Diagnostics Co Ltd
43% Upside
4593
Healios KK
131% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
64% Upside

Revenue
Forecast

Revenue Estimate
Upstream Bio Inc

For the last 1 year the compound annual growth rate for Upstream Bio Inc's revenue is 0%. The projected CAGR for the next 4 years is 25%.

0%
Past Growth
25%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Upstream Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Upstream Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is UPB's stock price target?
Price Target
48.96 USD

According to Wall Street analysts, the average 1-year price target for UPB is 48.96 USD with a low forecast of 35.35 USD and a high forecast of 78.75 USD.

What is Upstream Bio Inc's Revenue forecast?
Projected CAGR
25%

For the last 1 year the compound annual growth rate for Upstream Bio Inc's revenue is 0%. The projected CAGR for the next 4 years is 25%.

Back to Top